A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.
- DOI
- 10.1007/s00134-019-05593-2
- Published
- 2019-05-06
- Container
- Intensive Care Med
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00134-019-05593-2,
title = {A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.},
author = {Heyland DK and van Zanten ARH and Grau-Carmona T and Evans D and Beishuizen A and Schouten J and Hoiting O and Bordejé ML and Krell K and Klein DJ and Gonzalez J and Perez A and Brown R and James J and Harris MS and Investigators of the PROMOTE LP101-CL-201 Trial.},
year = {2019},
journal = {Intensive Care Med},
doi = {10.1007/s00134-019-05593-2},
url = {https://doi.org/10.1007/s00134-019-05593-2}
}RIS
TY - JOUR TI - A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial. AU - Heyland DK AU - van Zanten ARH AU - Grau-Carmona T AU - Evans D AU - Beishuizen A AU - Schouten J AU - Hoiting O AU - Bordejé ML AU - Krell K AU - Klein DJ AU - Gonzalez J AU - Perez A AU - Brown R AU - James J AU - Harris MS AU - Investigators of the PROMOTE LP101-CL-201 Trial. PY - 2019 JO - Intensive Care Med DO - 10.1007/s00134-019-05593-2 UR - https://doi.org/10.1007/s00134-019-05593-2 ER -
APA
DK, H., ARH, V. Z., T, G., D, E., A, B., J, S., O, H., ML, B., K, K., DJ, K., J, G., A, P., R, B., J, J., MS, H., & Trial., I. O. T. P. L. (2019). A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.. Intensive Care Med. https://doi.org/10.1007/s00134-019-05593-2
Source records
- europe-pmc · retrieved 2026-09-26T05:41:15.462Z